IMMU-17. HEMATOPOIETIC STEM CELL-DERIVED DENDRITIC CELLS REPROGRAM THE BRAIN TUMOR MICROENVIRONMENT

INTRODUCTION: Despite multimodality treatment, patients with malignant gliomas only achieve a median survival of 18 months. Our group has pioneered an adoptive T cell immunotherapy that utilizes total tumor RNA-pulsed dendritic cells to expand polyclonal tumor-reactive T cells ex-vivo. The strongest...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Wildes, Tyler, Flores, Catherine, DiVita, Bayli, Dyson, Kyle, Grippin, Adam, Mitchell, Duane
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2018
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012783/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.333
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk